KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Short-term Investments (2016 - 2023)

Amgen (AMGN) has 14 years of Short-term Investments data on record, last reported at $1.7 billion in Q4 2022.

  • For Q4 2022, Short-term Investments rose 3391.67% year-over-year to $1.7 billion; the TTM value through Dec 2022 reached $1.7 billion, up 3391.67%, while the annual FY2022 figure was $1.7 billion, 3391.67% up from the prior year.
  • Short-term Investments reached $1.7 billion in Q4 2022 per AMGN's latest filing, down from $2.0 billion in the prior quarter.
  • Across five years, Short-term Investments topped out at $22.4 billion in Q1 2018 and bottomed at $16.0 million in Q1 2022.
  • Average Short-term Investments over 5 years is $7.6 billion, with a median of $3.1 billion recorded in 2019.
  • The widest YoY moves for Short-term Investments: up 3391.67% in 2022, down 99.64% in 2022.
  • A 5-year view of Short-term Investments shows it stood at $22.4 billion in 2018, then tumbled by 87.15% to $2.9 billion in 2019, then soared by 52.44% to $4.4 billion in 2020, then plummeted by 98.9% to $48.0 million in 2021, then surged by 3391.67% to $1.7 billion in 2022.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $1.7 billion in Q4 2022, $2.0 billion in Q3 2022, and $2.0 billion in Q2 2022.